Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | netrin receptor unc 5 | 0.0015 | 0.1029 | 0.1029 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0015 | 0.1029 | 0.2393 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.4299 | 0.5 |
Schistosoma mansoni | netrin receptor unc5 | 0.0015 | 0.1029 | 0.2393 |
Echinococcus granulosus | death domain containing protein | 0.0015 | 0.1029 | 0.1029 |
Echinococcus granulosus | ankyrin repeat and death domain containing protein | 0.0015 | 0.1029 | 0.1029 |
Brugia malayi | Protein kinase domain containing protein | 0.0015 | 0.1029 | 0.2393 |
Echinococcus multilocularis | netrin receptor unc 5 | 0.0015 | 0.1029 | 0.1029 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.4299 | 0.4299 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0015 | 0.1047 | 0.2437 |
Brugia malayi | Uncoordinated protein 44 | 0.0015 | 0.1029 | 0.2393 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1047 | 1 |
Schistosoma mansoni | ankyrin 23/unc44 | 0.0015 | 0.1029 | 0.2393 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.4299 | 0.4299 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.4299 | 0.5 |
Onchocerca volvulus | Netrin receptor homolog | 0.0015 | 0.1029 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.4299 | 0.5 |
Echinococcus multilocularis | Ankyrin | 0.0015 | 0.1047 | 0.1047 |
Brugia malayi | hypothetical protein | 0.0038 | 0.4299 | 1 |
Echinococcus multilocularis | ankyrin repeat and death domain containing protein | 0.0015 | 0.1029 | 0.1029 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0015 | 0.1029 | 0.9823 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1029 | 0.9823 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1029 | 0.2393 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.4299 | 1 |
Brugia malayi | Death domain containing protein | 0.0015 | 0.1029 | 0.2393 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.4299 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.4299 | 0.5 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0077 | 1 | 1 |
Echinococcus granulosus | Ankyrin | 0.0015 | 0.1047 | 0.1047 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 34 % | Displacement of [3]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 1 uM | ChEMBL. | 18249548 |
Inhibition (binding) | = 34 % | Displacement of [3]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 1 uM | ChEMBL. | 18249548 |
Inhibition (binding) | = 38 % | Displacement of [3]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 1 uM | ChEMBL. | 18249548 |
Inhibition (binding) | = 38 % | Displacement of [3]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 1 uM | ChEMBL. | 18249548 |
Inhibition (binding) | = 69 % | Displacement of [3]NECA from human adenosine A3 receptor expressed in HeLa cells at 1 uM | ChEMBL. | 18249548 |
Inhibition (binding) | = 69 % | Displacement of [3]NECA from human adenosine A3 receptor expressed in HeLa cells at 1 uM | ChEMBL. | 18249548 |
Ki (binding) | = -5.43 | Displacement of [3]DPCPX from human adenosine A1 receptor expressed in CHO cells | ChEMBL. | 18249548 |
Log Ki (binding) | = 5.43 | Displacement of [3]DPCPX from human adenosine A1 receptor expressed in CHO cells | ChEMBL. | 18249548 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.